Nine oncology practices certified through ASCO Patient-Centered Cancer Care Certification pilot

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Nine outpatient oncology group practices have achieved certification through the new American Society of Clinical Oncology Patient-Centered Cancer Care Certification pilot. 

The ASCO Certification Program awarded certification to the first group of participants, including: Cancer & Hematology Centers of Western Michigan, Central Georgia Cancer Care, Hematology-Oncology Associates of CNY, Jefferson Health-Sidney Kimmel Cancer Center, Tennessee Oncology, The Center for Cancer and Blood Disorders, Nebraska Hematology-Oncology, PC, New England Cancer Specialists, and Memorial Cancer Institute.

“This first round of certifications is a major milestone for the success of this pilot, as it demonstrates that this new model for patient-centered cancer care delivery is achievable for all oncology practices, regardless of their practice setting,” Lori J. Pierce, chair of the Board of the Association for Clinical Oncology, said in a statement. 

The pilot includes 88 cancer care sites and nearly 500 oncologists from 12 participating practice groups and health systems. All pilot participants are on track to meet the standards and achieve certification in the coming months.

Certification is based on adherence to the Oncology Medical Home Standards: a single set of comprehensive, expert-backed standards for patient-centered care delivery, published by ASCO and the Community Oncology Alliance. 

The ASCO-COA Oncology Medical Home Standards focus on seven domains of cancer care, including: patient engagement; availability and access to care; evidence-based medicine; equitable and comprehensive team-based care; quality improvement; goals of care, palliative, and end-of-life care discussions; and chemotherapy safety.

To achieve certification, practices needed to meet a total of 17 care delivery standards and 22 chemotherapy safety standards, for a total of 39 standards.

The pilot is slated to end in summer 2023. 

Table of Contents

YOU MAY BE INTERESTED IN

Ivan Borrello, medical director of the Myeloma, Bone Marrow Transplant and Cell Therapies Program at Tampa General Hospital’s Cancer Institute, watched as flood waters from Hurricane Helene heaved against a contraption called the AquaFence, which is, as the name suggests, a water-impermeable barrier made of marine-grade laminate and various metals that can withstand storm surges of up to 15 feet above sea level. 
“When I joined ASCO in 2001, the most important thing to me was networking. I savored the opportunities to come to the annual meeting to meet and to talk with those who had led the studies that would inform standards of care, particularly in gynecologic oncology,” said Don S. Dizon. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login